{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:54:02Z","timestamp":1761854042202,"version":"build-2065373602"},"reference-count":84,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":60,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nefrolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.nefroe.2023.10.007","type":"journal-article","created":{"date-parts":[[2023,11,11]],"date-time":"2023-11-11T07:55:33Z","timestamp":1699689333000},"page":"531-545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients"],"prefix":"10.1016","volume":"43","author":[{"given":"Ver\u00f3nica","family":"L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auxiliadora","family":"Mazuecos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florentino","family":"Villanego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"L\u00f3pez-Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Beneyto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"D\u00edaz-Corte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Gonz\u00e1lez-Roncero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Guirado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Juega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Llorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Rodr\u00edguez-Benot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"S\u00e1nchez-Fructuoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Torregrosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sof\u00eda","family":"Z\u00e1rraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domingo","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nefroe.2023.10.007_bib0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/TP.0000000000003528","article-title":"Organ donation and transplantation during the COVID-19 pandemic: a summary of the Spanish experience","author":"Dom\u00ednguez-Gil","year":"2021","journal-title":"Transplantation."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0010","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1097\/TP.0000000000003291","article-title":"Ethical issues in the COVID era: doing the right thing depends on location, resources, and disease burden","volume":"104","author":"Stock","year":"2020","journal-title":"Transplantation."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0015","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.transproceed.2021.06.029","article-title":"Risk factors for mortality in stable kidney transplant patients infected by SARS-CoV-2 in the south of Spain","volume":"53","author":"L\u00f3pez","year":"2021","journal-title":"Transplant Proc."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0020","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1111\/ajt.16579","article-title":"Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: analysis of the Spanish Registry","volume":"21","author":"Villanego","year":"2021","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0025","unstructured":"Posicionamiento de la Sociedad Espa\u00f1ola de Nefrolog\u00eda ante la vacunaci\u00f3n frente al SARS-CoV-2 [accessed 18 Sep 2022]. Available from: https:\/\/www.revistanefrologia.com\/es-pdf-S0211699520302113."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0030","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/TP.0000000000003983","article-title":"The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant","volume":"106","author":"Sanders","year":"2022","journal-title":"Transplantation."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0035","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/ajt.16958","article-title":"mTOR inhibitors improve both humoral and cellular response to SARS-CoV-2 messenger RNA BNT16b2 vaccine in kidney transplant recipients","volume":"22","author":"Netti","year":"2022","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0040","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.7326\/L21-0282","article-title":"Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients: a case series","volume":"174","author":"Werbel","year":"2021","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0045","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/TP.0000000000004119","article-title":"Breakthrough infections following mRNA SARS-CoV-2 vaccination in kidney transplant recipients","volume":"106","author":"Mazuecos","year":"2022","journal-title":"Transplantation."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0050","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.nefro.2020.03.002","article-title":"Recomendaciones en el manejo de la pandemia por coronavirus SARS-CoV-2 (Covid-19) en pacientes con trasplante renal","volume":"40","author":"L\u00f3pez","year":"2020","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.nefro.2021.01.001","article-title":"Trasplante renal despu\u00e9s de una COVID-19","volume":"41","author":"Pascual","year":"2021","journal-title":"Nefrolog\u00eda."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0060","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/ajt.16905","article-title":"Kidney transplantation from SARS-CoV-2-positive deceased donor","volume":"22","author":"Molnar","year":"2022","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0065","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1111\/ajt.16765","article-title":"Early success transplanting kidneys from donors with new SARS-CoV-2 RNA positivity: a report of 10 cases","volume":"21","author":"Koval","year":"2021","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0070","unstructured":"ONT [accessed 18 Sep 2022] Available from: https:\/\/www.ont.es\/wp-content\/uploads\/2023\/10\/Recommendations-donacion-y-trasplante-frente-a-la-COVID-19-octubre-2023.pdf."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0075","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/TP.0000000000004151","article-title":"The global impact of COVID-19 on solid organ transplantation: two years into a pandemic","volume":"106","author":"Nimmo","year":"2022","journal-title":"Transplantation."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0080","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1097\/TP.0000000000004200","article-title":"Update on COVID-19 therapeutics for solid organ transplant recipients, including the omicron surge","volume":"106","author":"Avery","year":"2022","journal-title":"Transplantation."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0085","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14495","article-title":"SARS-COV-2 vaccination with BNT162B2 in renal transplant patients: risk factors for impaired response and immunological implications","volume":"36","author":"Russo","year":"2022","journal-title":"Clin Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0090","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/ajt.16829","article-title":"Protecting kidney transplant recipients against SARS-CoV-2 infection: a third dose of vaccine is necessary now","volume":"22","author":"Villanego","year":"2022","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0095","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/ajt.16854","article-title":"Negative immune responses to two-dose mRNA COVID-19 vaccines in renal allograft recipients assessed with simple antibody and interferon gamma release assay cellular monitoring","volume":"22","author":"Crespo","year":"2022","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0100","article-title":"Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study","author":"Quiroga","year":"2021","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0105","unstructured":"Grupo de trabajo t\u00e9cnico de vacunaci\u00f3n COVID-19, de la Ponencia de Programa y Registro de Vacunaciones. Estrategia de Vacunaci\u00f3n frente a COVID-19 en Espa\u00f1a. Actualizaci\u00f3n 9. Ministerio de Sanidad, octubre 2021. [accessed 3 Sep 2022] Available from: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/covid19\/Actualizaciones_Estrategia_Vacunacion\/docs\/COVID-19_Actualizacion9_Modificada_EstrategiaVacunacion.pdf."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0110","unstructured":"Grupo de trabajo t\u00e9cnico de vacunaci\u00f3n COVID-19, de la Ponencia de Programa y Registro de Vacunaciones. Estrategia de Vacunaci\u00f3n frente a COVID-19 en Espa\u00f1a. Actualizaci\u00f3n 11. Ministerio de Sanidad, febrero 2022. [accessed 3 Sep 2022] Available from: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/covid19\/Actualizaciones_Estrategia_Vacunacion\/docs\/COVID-19_Actualizacion11_EstrategiaVacunacion.pdf."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0115","unstructured":"Ministerio de Sanidad. Gu\u00eda sobre utilizaci\u00f3n de vacunas para personal sanitario. Estrategia de vacunaci\u00f3n frente a COVID-19. [accessed aa Sep 2022] Available from: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/covid19\/docs\/COVID-19_Guia_utilizacion_vacunas_personalsanitario.pdf."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0120","unstructured":"Ponencia de Programa y Registro de Vacunaciones. Recomendaciones de utilizaci\u00f3n de Evusheld para la prevenci\u00f3n de COVID-19. [accessed 2 Sep 2022] Available from: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/covid19\/docs\/Recomendaciones_uso_Evusheld.pdf."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0125","first-page":"367","article-title":"Posicionamiento de la Sociedad Espa\u00f1ola de Nefrolog\u00eda ante la vacunaci\u00f3n frente al SARS-CoV-2","volume":"4","author":"S\u00e1nchez-\u00c1lvarez","year":"2021","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0130","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14478","article-title":"Kidney transplant recipients vaccinated before transplantation maintain superior humoral response to SARS-CoV-2 vaccine","volume":"35","author":"Grupper","year":"2021","journal-title":"Clin Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0135","article-title":"Stopping of mycophenolic acid in kidney transplant recipients for 2 weeks peri-vaccination does not increase response to SARS-CoV-2 vaccination-a non-randomized, controlled pilot study","volume":"9","author":"Regele","year":"2022","journal-title":"Front Med (Lausanne)."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0140","doi-asserted-by":"crossref","first-page":"e426","DOI":"10.1097\/TP.0000000000004240","article-title":"Perivaccination antimetabolite hold and third dose of SARS-CoV-2 vaccine in lung transplant recipients: preliminary report","volume":"106","author":"Frey","year":"2022","journal-title":"Transplantation."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0145","unstructured":"Wang AX. Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients (ADIVKT). [accessed 1 Sep 2022] Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05060991."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0150","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0155","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.17141","article-title":"Incidence and severity of SARS-CoV-2 infections in liver and kidney transplant recipients in the post-vaccination era: real-life data from Denmark","author":"Hamm","year":"2022","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0160","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1111\/ajt.17095","article-title":"Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: a population-based cohort study from Canada","volume":"22","author":"Naylor","year":"2022","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0165","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10204","article-title":"Immune response to third dose BNT162b2 COVID-19 vaccine among kidney transplant recipients-A prospective Study","volume":"35","author":"Yahav","year":"2022","journal-title":"Transpl Int."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0170","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2021.10026","article-title":"Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA vaccine immunogenicity in kidney transplant recipients","volume":"35","author":"Haller","year":"2022","journal-title":"Transpl Int."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0175","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/ndt\/gfab352","article-title":"mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?","volume":"37","author":"Wijtvliet","year":"2022","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0180","unstructured":"Grupo de trabajo t\u00e9cnico de vacunaci\u00f3n COVID-19, de la Ponencia de Programa y Registro de Vacunaciones. Estrategia de Vacunaci\u00f3n frente a COVID-19 en Espa\u00f1a. Actualizaci\u00f3n 3. Ministerio de Sanidad, febrero 2021. [accessed 12 Sep 2022] Available from: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/covid19\/Actualizaciones_Estrategia_Vacunacion\/docs\/COVID-19_Actualizacion3_EstrategiaVacunacion.pdf."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0185","unstructured":"Grupo de trabajo t\u00e9cnico de vacunaci\u00f3n COVID-19, de la Ponencia de Programa y Registro de Vacunaciones. Estrategia de Vacunaci\u00f3n frente a COVID-19 en Espa\u00f1a. Actualizaci\u00f3n 4. Ministerio de Sanidad, febrero 2021. [accessed 12 Sep 2022] Available from: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/covid19\/Actualizaciones_Estrategia_Vacunacion\/docs\/COVID-19_Actualizacion4_EstrategiaVacunacion.pdf."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0190","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/ajt.16966","article-title":"Comparison of the immunogenicity of ChAdOx1 nCoV-19 vaccine against the wild-type and delta variants in kidney transplant recipients and healthy volunteers","volume":"22","author":"Watcharananan","year":"2022","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0195","unstructured":"Grupo de trabajo t\u00e9cnico de vacunaci\u00f3n COVID-19, de la Ponencia de Programa y Registro de Vacunaciones. Estrategia de Vacunaci\u00f3n frente a COVID-19 en Espa\u00f1a. Actualizaci\u00f3n 5. Ministerio de Sanidad, marzo 2021. [accessed 29 Aug 2022] Available from: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/covid19\/Actualizaciones_Estrategia_Vacunacion\/docs\/COVID-19_Actualizacion5_EstrategiaVacunacion.pdf."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0200","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.1097\/TP.0000000000003850","article-title":"Antibody response to the Janssen COVID-19 vaccine in solid organ transplant recipients","volume":"105","author":"Boyarsky","year":"2021","journal-title":"Transplantation."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0205","unstructured":"European Medicines Agency (EMA). Nuvaxovid Product information. [accessed 29 Aug 2022] Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/nuvaxovid-epar-product-information_en.pdf."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0210","unstructured":"Ponencia de Programa y Registro de Vacunaciones. Recomendaciones de vacunaci\u00f3n frente a COVID-19 para el oto\u00f1o en Espa\u00f1a. [accessed 20 Oct 2022] Available from: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/covid19\/docs\/Recomendaciones_vacunacion_Otono_Covid_VF.pdf."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0215","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1056\/NEJMoa2116620","article-title":"Intramuscular AZD7442 (Tixagevimab-Cilgavimab) for prevention of Covid-19","volume":"386","author":"Levin","year":"2022","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0220","unstructured":"Food and Drug Administration. FDA authorizes revisions to Evusheld dosing. February 24, 2022. [accessed 13 Sep 2022] Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-authorizes-revisions-evusheld-dosing."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0225","unstructured":"COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. [accessed 13 Sep 2022] Available from: https:\/\/www.covid19treatmentguidelines.nih.gov\/."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0230","unstructured":"Recomendaciones SEIMC para el manejo cl\u00ednico de pacientes con COVID-19. Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. [accessed 9 Sep 2022] Available from: https:\/\/covid19.seimc.org\/index.php\/recomendaciones-seimc-para-el-manejo-clinico-de-pacientes-con-covid-19\/."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0235","unstructured":"Criterios para valorar la administraci\u00f3n de las nuevas alternativas terap\u00e9uticas antivirales frente a la infecci\u00f3n por SARS-CoV-2. Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. 2 de noviembre de 2022. [accessed 2 Nov 2022] Available from: https:\/\/www.aemps.gob.es\/medicamentos-de-uso-humano\/acceso-a-medicamentos-en-situaciones-especiales\/criterios-para-valorar-la-administracion-de-las-nuevas-alternativas-terapeuticas-antivirales-frente-a-la-infeccion-por-sars-cov-2\/."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0240","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0245","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1111\/ajt.16955","article-title":"Nirmatrelvir\/ritonavir use: managing clinically significant drug-drug interactions with transplant immunosuppressants","volume":"22","author":"Lange","year":"2022","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0250","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/ajt.17027","article-title":"Early clinical experience with nirmatrelvir\/ritonavir for the treatment of COVID-19 in solid organ transplant recipients","volume":"22","author":"Salerno","year":"2022","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0255","unstructured":"American Society of Transplantation: AST statement on oral antiviral therapy for COVID-19 for organ transplant recipients, 2022 [accessed 11 Sep 2022] Available from: https:\/\/www.myast.org\/sites\/default\/files\/AST%20Statement%20on%20Oral%20Antiviral%20Therapy%20for%20COVID%20Jan%204%20%282%29.pdf."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0260","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2215\/CJN.05270522","article-title":"Prescribing nirmatrelvir\/ritonavir for COVID-19 in advanced CKD","volume":"17","author":"Hiremath","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0265","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2116846","article-title":"Early remdesivir to prevent progression to severe Covid-19 in outpatients","volume":"386","author":"Gottlieb","year":"2022","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0270","doi-asserted-by":"crossref","first-page":"269","DOI":"10.34067\/KID.0006152021","article-title":"A propensity score-matched observational study of remdesivir in patients with COVID-19 and severe kidney disease","volume":"3","author":"Seethapathy","year":"2021","journal-title":"Kidney360."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0275","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.ekir.2021.06.023","article-title":"Use and safety of remdesivir in kidney transplant recipients with COVID-19","volume":"6","author":"Buxeda","year":"2021","journal-title":"Kidney Int Rep."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0280","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N Engl J Med."},{"issue":"11","key":"10.1016\/j.nefroe.2023.10.007_bib0285","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1093\/ckj\/sfad184","article-title":"Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in patients on kidney replacement therapy: observational study using the OpenSAFELY-UKRR and SRR databases","volume":"16","author":"Zheng","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.nefroe.2023.10.007_bib0290","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000004306","article-title":"Preliminary clinical experience of molnupiravir to prevent progression of COVID-19 in kidney transplant recipients","author":"Villamar\u00edn","year":"2022","journal-title":"Transplantation."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0295","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfac177","article-title":"Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients","author":"Villanego","year":"2022","journal-title":"Clin Kidney J."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0300","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-31615-7","article-title":"Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains","volume":"13","author":"Case","year":"2022","journal-title":"Nat Commun."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0305","unstructured":"Food and Drug Administration. FDA updates Sotrovimab emergency use authorization. April 5, 2022. [accessed 11 Sep 2022] Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-updates-sotrovimab-emergency-use-authorization."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0310","unstructured":"European Medicines Agency. Xevudy. Procedural steps taken and scientific information after the authorization. 2022. [accessed 11 Sep 2022] Available from: https:\/\/www.ema.europa.eu\/en\/documents\/procedural-steps-after\/xevudy-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2022.06.033","article-title":"Sotrovimab to prevent severe COVID-19 in high-risk patients infected with Omicron BA.2","volume":"85","author":"Martin-Blondel","year":"2022","journal-title":"J Infect."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0320","unstructured":"Coronavirus antiviral & resistence database. Stanford University. 2022 [accessed 12 Sep 2022] Available from: https:\/\/covdb.stanford.edu\/susceptibility-data\/table-mab-susc\/."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0325","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0330","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13901","article-title":"Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild-to-moderate coronavirus disease 2019 during the Omicron epoch","volume":"24","author":"Yetmar","year":"2022","journal-title":"Transpl Infect Dis."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0335","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1097\/TP.0000000000004278","article-title":"Bebtelovimab for treatment of COVID-19 in ambulatory solid organ transplant recipients","volume":"106","author":"Shertel","year":"2022","journal-title":"Transplantation."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0340","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S2213-2600(22)00180-1","article-title":"Efficacy and safety of intramuscular administration of tixagevimab-cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"10","author":"Montgomery","year":"2022","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0345","article-title":"Tixagevimab-cilgavimab as an early treatment for COVID-19 in kidney transplant recipients","author":"Benotmane","year":"2022","journal-title":"medRxiv."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0350","unstructured":"Evusheld: EPAR \u2013 Product Information. [accessed 26 Sep 2022] Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-inf."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0355","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1111\/ajt.16192","article-title":"Use of tocilizumab in kidney transplant recipients with COVID-19","volume":"20","author":"P\u00e9rez-S\u00e1ez","year":"2020","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0360","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S2213-2600(21)00331-3","article-title":"Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial","volume":"9","author":"Marconi","year":"2021","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0365","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/iid3.563","article-title":"A randomized controlled clinical trial on efficacy and safety of anakinra in patients with severe COVID-19","volume":"10","author":"Kharazmi","year":"2022","journal-title":"Immun Inflamm Dis."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0370","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1586\/eri.11.43","article-title":"Management of viral infections in solid organ transplant recipients","volume":"9","author":"Razonable","year":"2011","journal-title":"Expert Rev Anti Infect Ther."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0375","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1111\/ajt.16185","article-title":"COVID-19 and kidney transplantation: results from the TANGO International Transplant Consortium","volume":"20","author":"Cravedi","year":"2020","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0380","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/ckj\/sfab025","article-title":"Immunosuppression minimization in kidney transplant recipients hospitalized for COVID-19","volume":"14","author":"Anton Pampols","year":"2021","journal-title":"Clin Kidney J."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0385","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMc2011117","article-title":"Covid-19 and kidney transplantation","volume":"382","author":"Akalin","year":"2020","journal-title":"N Engl J Med."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0390","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/ajt.15941","article-title":"COVID-19 in solid organ transplant recipients: initial report from the US epicenter","volume":"20","author":"Pereira","year":"2020","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0395","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/ajt.15929","article-title":"COVID-19 in solid organ transplant recipients: a single-center case series from Spain","volume":"20","author":"Fern\u00e1ndez-Ruiz","year":"2020","journal-title":"Am J Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0400","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.kint.2020.04.002","article-title":"A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia","volume":"97","author":"Alberici","year":"2020","journal-title":"Kidney Int."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0405","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14376","article-title":"Immunosuppression practices during the COVID-19 pandemic: a multinational survey study of transplant programs","volume":"35","author":"Sandal","year":"2021","journal-title":"Clin Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0410","article-title":"Management of immunosuppressive therapy in kidney transplant recipients with COVID19. A multicentre national study derived form the S.E.N. COVID registry [Article in Spanish]","author":"L\u00f3pez-Oliva","year":"2022","journal-title":"Nefrologia."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0415","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfac203","article-title":"Issues regarding COVID-19 in kidney transplantation in the era of the omicron variant: a commentary by the era descartes working group","author":"Gandolfini","year":"2022","journal-title":"Nephrol Dial Transplant."},{"key":"10.1016\/j.nefroe.2023.10.007_bib0420","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ekir.2022.01.1072","article-title":"Occurrence of De novo donor-specific antibodies after COVID-19 in kidney transplant recipients is low despite immunosuppression modulation","volume":"7","author":"Masset","year":"2022","journal-title":"Kidney Int Rep."}],"container-title":["Nefrolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251423001694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2013251423001694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:50:42Z","timestamp":1761853842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2013251423001694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2013251423001694"],"URL":"https:\/\/doi.org\/10.1016\/j.nefroe.2023.10.007","relation":{},"ISSN":["2013-2514"],"issn-type":[{"type":"print","value":"2013-2514"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients","name":"articletitle","label":"Article Title"},{"value":"Nefrolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nefroe.2023.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nefro.2022.11.001","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedad Espa\u00f1ola de Nefrolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}